Metagenomi inks $175m Series B

Metagenomi, a genetic medicines company, has raised $175 million in Series B financing.

Metagenomi, a genetic medicines company, has raised $175 million in Series B financing. The backers include PFM Health Sciences and Farallon Capital Management.

Source: Press Release